|
|
|
| A Comparative Analysis of The Service Supply of Knowledge-Intensive Business Services and the Development of Pharmaceutical Industry in China and America |
| Wu Lihua1,Wang Xincheng1,Yin Xunian2 |
1.School of Economics and Management,Southeast University,Nanjing 211189,China;
2.School of Economics,Shanghai University of Finance and Economics,Shanghai 200433,China |
|
|
|
|
Abstract In this paper,We divides the KIBS into professional-based knowledge-intensive business services(P-KIBS) and technology-based knowledge-intensive business services(T-KIBS).Then we compares the backward linkage ratio between pharmaceutical industry and two types of KIBS in China and America.The results show that the backward linkage ratio between pharmaceutical industry and two types of KIBS in America are significantly higher than that of China.In P-KIBS.The backward linkage ratio between pharmaceutical industry and business services is significantly higher than that of China;In T-KIBS,the backward linkage ratio between pharmaceutical industry and R&D services is significantly lower than that of China,whereas the R&D intensity of American pharmaceutical companies is far higher than that of China.The development model of pharmaceutical industry in China and America have significant difference.In America,the R&D of pharmaceutical industry is oriented by companies and companies pay more attention to the service which support the process of products marketing,while in China,the R&D of pharmaceutical industry is dominated by research institutions,and the companies pay more emphasis on promoting the fruit of research institutions to business transformation
|
|
Received: 22 August 2016
|
|
|
|
|
|
[1] CIRIACI D,MONTRESOR S,PALMA D.Do KIBS make manufacturing more innovative?An empirical investigation of four European countries[J].Technological forecasting & social change,2014,95:135-151.
[2]HIPP C,GALLEGO J,RUBALCABA L.Shaping innovation in European knowledge-intensive business services[J].Service business,2015,9(1):41-55.
[3]DOLOREUX D,SHEARMUR R.Collaboration,information and the geography of innovation in knowledge intensive business services[J].Journal of economic geography,2012,12(1):79-105.
[4]郝凤霞.基于创新网络的美国生物医药产业研究[J].科学学研究,2005,23(S1):288-291.
[5]KOWALKOWSKI C,KINDSTRM D,ALEJANDRO T B,et al.Service infusion as agile incrementalism in action[J].Journal of business research,2012,65(6):765-772.
[6]MALERBA F.Innovation and the dynamics and evolution of industries:progress and challenges[J].International journal of industrial organization,2007,25(4):675-699.
[7]王文涛,付剑峰,朱义.企业创新、价值链扩张与制造业盈利能力——以中国医药制造企业为例[J].中国工业经济,2012(4):50-62
[8]孙燕,孙利华.中、美、日三国政府医药研发投入管理比较研究[J].中国医药工业杂志,2010,41(6):472-476.
[9]陈文婕,颜克高.新兴低碳产业发展策略研究[J].经济地理,2010,30(2):200-203.
[10]HILL E W,BRENNAN J F.A methodology for identifying the drivers of industrial clusters:the foundation of regional competitive advantage[J].Economic development quarterly,2000,14(1):65-96.
[11]SCHETTKAT R,YOCARINI L.The shift to services employment:a review of the literature[J].Structural change & economic dynamics,2006,17(2):127-147.
[12]MILES I.Patterns of innovation in service industries[J].Ibm systems journal,2008,47(1):115-128.
[13]PINTO H,FERNANDEZESQUINAS M,UYARRA E.Universities and knowledge-intensive business services(KIBS) as sources of knowledge for innovative firms in peripheral regions[J].Regional studies,2015,49(11):1873-1891.
[14]赵尚梅,李勇,庞玉锋.保险业对经济增长贡献的理论模型与实证检验[J].保险研究,2009(1):51-56.
[15]阿丽塔,刘晓婷,张玢,张燕舞,武志昂.基于专利计量的中美医药产业创新网络对比分析[J].中国新药杂志,2014,23(11):1237-1247.
[16]刘玉成,孙利华.中美医药产业链的比较及启示[J].沈阳药科大学学报,2013,30(6):474-477.
[17]孙燕,孙利华.我国政府医药科技投入对企业研发支出影响的实证分析[J].中国药房,2011,22(9):771-774.
[18]张世娟,冯国忠.政府研发资助对大中型医药企业研发投入的效应分析[J].中国药事,2015,29(8):793-798. |
|
|
|
2017, Vol. 0 
